Cytocom, Inc. (CBLI)
CBLIPrice: $3.17
Fair Value: 🔒
🔒score
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees. The firm is engaged in developing approaches to activate the immune system and addr... more
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and d... more
Description
Shares
| Market Cap | $226.39M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Yakov Kogan |
| IPO Date | 2006-07-21 | CAGR | 0.08% |
| Employees | 18 | Website | www.cytocom.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
CBLI chart loading...
Fundamentals
Technicals
| Enterprise Value | $70.89M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 860.98 | P/B Ratio | 19.52 |
| P/CF Ratio | -16.56 | P/FCF Ratio | -95.4 |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -94.91% | Gross Margin | 1% |
| Operating Margin | -9.84% | Profit Margin | -9.12% |
| ROE | -1.6% | ROA | -1.03% |
| ROCE | -1.28% | Current Ratio | 7.6 |
| Quick Ratio | 7.6 | Cash Ratio | 6.39 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | 435.14 | Piotroski Score | 1 |